U.S. Physical Therapy, Inc. (NYSE:USPH) Announces $0.45 Dividend

U.S. Physical Therapy, Inc. (NYSE:USPH) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Investors of record on Friday, March 14th will be given a dividend of 0.45 per share on Friday, April 11th. The ex-dividend date is Friday, March 14th.

U.S. Physical Therapy has increased its dividend by an average of 6.4% per year over the last three years. U.S. Physical Therapy has a dividend payout ratio of 55.3% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect U.S. Physical Therapy to earn $2.93 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 60.1%.

U.S. Physical Therapy Price Performance

USPH traded down $5.47 during trading on Thursday, hitting $82.25. The company’s stock had a trading volume of 275,173 shares, compared to its average volume of 97,149. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63. The business’s fifty day simple moving average is $88.41 and its 200 day simple moving average is $87.67. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 87.50, a P/E/G ratio of 3.54 and a beta of 1.48.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities research analysts forecast that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

Insider Buying and Selling

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the sale, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on USPH shares. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research reissued an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JPMorgan Chase & Co. lifted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. Finally, JMP Securities initiated coverage on U.S. Physical Therapy in a research note on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $114.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.